Esperance Schaefer

2.1k total citations
45 papers, 1.1k citations indexed

About

Esperance Schaefer is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Esperance Schaefer has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 22 papers in Hepatology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Esperance Schaefer's work include Liver Disease Diagnosis and Treatment (23 papers), Hepatitis C virus research (15 papers) and Alcohol Consumption and Health Effects (11 papers). Esperance Schaefer is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Hepatitis C virus research (15 papers) and Alcohol Consumption and Health Effects (11 papers). Esperance Schaefer collaborates with scholars based in United States, China and France. Esperance Schaefer's co-authors include Raymond T. Chung, Raymond T. Chung, Wenyu Lin, Jay Luther, Patricia P. Bloom, Lee F. Peng, Dahlene N. Fusco, Cynthia Brisac, Russell P. Goodman and Jenna Gustafson and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and SHILAP Revista de lepidopterología.

In The Last Decade

Esperance Schaefer

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esperance Schaefer United States 20 518 398 269 209 173 45 1.1k
Alicja Wiercińska‐Drapało Poland 17 459 0.9× 274 0.7× 334 1.2× 344 1.6× 150 0.9× 119 1.3k
Martin F. Sprinzl Germany 25 817 1.6× 801 2.0× 179 0.7× 237 1.1× 300 1.7× 69 1.6k
Isabel Ojanguren Spain 24 756 1.5× 398 1.0× 224 0.8× 301 1.4× 144 0.8× 53 1.6k
Nora A. Fierro Mexico 18 359 0.7× 411 1.0× 156 0.6× 142 0.7× 245 1.4× 51 867
F. Berger Germany 19 541 1.0× 486 1.2× 262 1.0× 191 0.9× 28 0.2× 75 1.2k
Zenichi Morise Japan 22 260 0.5× 482 1.2× 131 0.5× 215 1.0× 225 1.3× 92 1.5k
Antonio Riva United Kingdom 19 971 1.9× 742 1.9× 279 1.0× 472 2.3× 510 2.9× 41 1.7k
Myoung Kuk Jang South Korea 23 1.1k 2.1× 1.0k 2.6× 102 0.4× 312 1.5× 227 1.3× 75 2.0k
Elisabetta Loggi Italy 20 1.3k 2.5× 1.1k 2.9× 200 0.7× 150 0.7× 474 2.7× 58 1.8k

Countries citing papers authored by Esperance Schaefer

Since Specialization
Citations

This map shows the geographic impact of Esperance Schaefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esperance Schaefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esperance Schaefer more than expected).

Fields of papers citing papers by Esperance Schaefer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esperance Schaefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esperance Schaefer. The network helps show where Esperance Schaefer may publish in the future.

Co-authorship network of co-authors of Esperance Schaefer

This figure shows the co-authorship network connecting the top 25 collaborators of Esperance Schaefer. A scholar is included among the top collaborators of Esperance Schaefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esperance Schaefer. Esperance Schaefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parker, Richard, Guruprasad P. Aithal, Michael Allison, et al.. (2025). Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease. The American Journal of Gastroenterology.
2.
Corey, Kathleen E., et al.. (2024). Prevalence and Clinical Correlation of Cardiometabolic Risk Factors in Alcohol-Related Liver Disease and Metabolic Dysfunction and Alcohol Associated Liver Disease (MetALD). Journal of Clinical and Experimental Hepatology. 15(3). 102492–102492. 3 indexed citations
3.
Shay, Jessica E.S., Augustin Vannier, Stephanie Tsai, et al.. (2023). Moderate-high intensity exercise associates with reduced incident alcohol-associated liver disease in high-risk patients. Alcohol and Alcoholism. 58(5). 472–477. 3 indexed citations
4.
James, Kaitlyn E., et al.. (2022). Trends in gestational age at delivery for intrahepatic cholestasis of pregnancy and adoption of society guidelines. American Journal of Obstetrics & Gynecology MFM. 4(6). 100709–100709. 4 indexed citations
5.
Tsai, Stephanie, et al.. (2022). Creation of an Inpatient Alcohol Liver Service Improves Early Liver Disease Detection in Patients With Alcohol Use Disorder. Clinical Gastroenterology and Hepatology. 21(6). 1646–1648. 13 indexed citations
6.
Vannier, Augustin, Raymond T. Chung, Suraj J. Patel, et al.. (2022). Substance Use Disorder Is Associated With Alcohol-Associated Liver Disease in Patients With Alcohol Use Disorder. SHILAP Revista de lepidopterología. 1(3). 403–408. 5 indexed citations
7.
Salloum, Shadi, Annie J. Kruger, Jacinta A. Holmes, et al.. (2021). Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase. Cellular and Molecular Gastroenterology and Hepatology. 12(4). 1297–1310. 37 indexed citations
8.
Vannier, Augustin, Dmitriy Kedrin, Raymond T. Chung, et al.. (2021). Serum HMGB1 associates with liver disease and predicts readmission and mortality in patients with alcohol use disorder. Alcohol. 95. 37–43. 9 indexed citations
9.
Holmes, Jacinta A., Eoin R. Feeney, Annie J. Kruger, et al.. (2018). Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection. The Journal of Infectious Diseases. 218(9). 1394–1403. 36 indexed citations
10.
Olson, Kristian R., Amir H. Davarpanah, Esperance Schaefer, Nahel Elias, & Joseph Misdraji. (2017). Case 2-2017. New England Journal of Medicine. 376(3). 268–278. 7 indexed citations
11.
Kumthip, Kattareeya, Jian Hong, Chuanlong Zhu, et al.. (2016). HCV induces transforming growth factor β1 through activation of endoplasmic reticulum stress and the unfolded protein response. Scientific Reports. 6(1). 22487–22487. 58 indexed citations
12.
Schaefer, Esperance, James Meixiong, Amy Deik, et al.. (2016). Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C. World Journal of Gastroenterology. 22(45). 9954–9954. 5 indexed citations
13.
Lin, Wenyu, Chuanlong Zhu, Jian Hong, et al.. (2014). The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing. Journal of Hepatology. 62(5). 1024–1032. 21 indexed citations
14.
Chung, Raymond T., Wenyu Lin, Chuanlong Zhu, et al.. (2013). Health care quality and cost effectiveness. Hepatology. 58(S1). 328A–331A. 3 indexed citations
15.
Jilg, Nikolaus, Wenyu Lin, Jian Hong, et al.. (2013). Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus. Hepatology. 59(4). 1250–1261. 89 indexed citations
16.
Schaefer, Esperance & Raymond T. Chung. (2012). Anti−Hepatitis C Virus Drugs in Development. Gastroenterology. 142(6). 1340–1350.e1. 81 indexed citations
17.
Kumthip, Kattareeya, Nikolaus Jilg, Lei Zhao, et al.. (2012). Hepatitis C Virus NS5A Disrupts STAT1 Phosphorylation and Suppresses Type I Interferon Signaling. Journal of Virology. 86(16). 8581–8591. 68 indexed citations
18.
Peng, Lee F., Esperance Schaefer, Andrew Berical, et al.. (2011). Ceestatin, a Novel Small Molecule Inhibitor of Hepatitis C Virus Replication, Inhibits 3-Hydroxy-3-Methylglutaryl-Coenzyme A Synthase. The Journal of Infectious Diseases. 204(4). 609–616. 11 indexed citations
19.
Schaefer, Esperance & Raymond T. Chung. (2011). The Impact of Human Gene Polymorphisms on HCV Infection and Disease Outcome. Seminars in Liver Disease. 31(4). 375–386. 17 indexed citations
20.
Strength, D.R., Esperance Schaefer, & W. D. Salmon. (1951). The Relation of Vitamin B12 and Folacin to the Utilization of Choline and its Precursors for Lipotropism and Renal Protection in Rats. Journal of Nutrition. 45(3). 329–343. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alicja Wiercińska‐Drapało Breakdown of academic impact, for papers by Martin F. Sprinzl Breakdown of academic impact, for papers by Isabel Ojanguren Breakdown of academic impact, for papers by Nora A. Fierro Breakdown of academic impact, for papers by F. Berger Breakdown of academic impact, for papers by Zenichi Morise Breakdown of academic impact, for papers by Antonio Riva Breakdown of academic impact, for papers by Myoung Kuk Jang Breakdown of academic impact, for papers by Elisabetta Loggi
Rankless by CCL
2026